Physiologic MR Imaging of Salivary Gland Tumors
ConditionSalivary Gland Tumor
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAbramson Cancer Center at Penn Medicine
About this trial
The goal of this study is to use advanced Magnetic Resonance Imaging (MRI) techniques to help identify the difference between cancerous and non-cancerous salivary gland tumors for improving treatment strategies and to aid in the prediction of disease progression.
Eligibility criteria
Qualifiers
Possess a salivary gland lesion of 1cm3 size
Have no prior history of treatment for salivary gland lesion
Disqualifiers
Has any prior history of cancer other than SGT
Has any MRI contra-indications
Has a history of known renal disease.
Has history of prior radiation to head and neck region
Trial design
Treatments tested in this trial
- MRI
Treatment groups
30 Participants
are divided into 1 treatment groupSponsors and collaborators
Abramson Cancer Center at Penn Medicine
Lead sponsor
University of Pennsylvania
Sponsor institution
McCabe Fund
Collaborator
Source ClinicalTrials.gov